Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Covance 3Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Covance 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Covance

3Q Revenues: $415 mlllion (+16%)

3Q Earnings: $45 million (+17%)

YTD Revenues: $1.2 billion (+14%)

YTD Earnings: $125 million (+17%)

Comments: Early development results were up 19% to $200 million, while late-stage services rose 13% to $197 million. During the quarter, the company opened four new facilities: a preclinical ABSL-2 vaccine facility in North America, a preclinical facility expansion in Europe, and two sites in Aisa, a central laboratory and a nutritional chemistry laboratory.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics